Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vasogen Inc (NYSE:MEW - TSE:VAS) Immune Modulation Therapies -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (8)	2/17/2001 9:37:20 AM
From: tom pope	Read Replies (1) \| Respond to of 26

From the end of an interview with a Merrill money manager in TSC >>Ian McDonald: Great. What was the last new name added to the fund's portfolio, and to your own portfolio, backing up current trades, obviously? Kevin Rendino: Let me see. The last name? The last name might have been Gillette somewhere in the upper 20s, lower 30s. And the last one in my personal account is a company called Vasogen (MEW:Amex - news - boards). It's a biotech stock. And we know some people on the board there and it's a pretty interesting name. I do in my personal account what I can't do in my fund.< Pretty sad chart, tho.